AMERICAN SOCIETY OF HEMATOLOGY has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN
Measure | Date | Value |
---|
2022 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2022 401k financial data |
---|
Total income from all sources (including contributions) | 2022-12-31 | $-2,678,388 |
Total of all expenses incurred | 2022-12-31 | $729,796 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $672,324 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $2,987,860 |
Value of total assets at end of year | 2022-12-31 | $35,849,480 |
Value of total assets at beginning of year | 2022-12-31 | $39,257,664 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $57,472 |
Total interest from all sources | 2022-12-31 | $184,945 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $1,163,494 |
Participant contributions at end of year | 2022-12-31 | $80,214 |
Participant contributions at beginning of year | 2022-12-31 | $71,785 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $379,157 |
Other income not declared elsewhere | 2022-12-31 | $174,808 |
Administrative expenses (other) incurred | 2022-12-31 | $57,472 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-3,408,184 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $35,849,480 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $39,257,664 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $28,865,118 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $32,491,403 |
Value of interest in pooled separate accounts at end of year | 2022-12-31 | $1,218,866 |
Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $1,157,895 |
Interest on participant loans | 2022-12-31 | $3,449 |
Interest earned on other investments | 2022-12-31 | $181,496 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $5,685,282 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $5,536,581 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-6,121,686 |
Net investment gain/loss from pooled separate accounts | 2022-12-31 | $95,685 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $1,445,209 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $672,324 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | GELMAN ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2022-12-31 | 521392008 |
2021 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2021 401k financial data |
---|
Total income from all sources (including contributions) | 2021-12-31 | $7,009,774 |
Total of all expenses incurred | 2021-12-31 | $670,735 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $560,928 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $2,576,490 |
Value of total assets at end of year | 2021-12-31 | $39,257,664 |
Value of total assets at beginning of year | 2021-12-31 | $32,918,625 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $109,807 |
Total interest from all sources | 2021-12-31 | $162,967 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $1,073,640 |
Participant contributions at end of year | 2021-12-31 | $71,785 |
Participant contributions at beginning of year | 2021-12-31 | $42,626 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $155,280 |
Other income not declared elsewhere | 2021-12-31 | $180,513 |
Administrative expenses (other) incurred | 2021-12-31 | $109,807 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $6,339,039 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $39,257,664 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $32,918,625 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $32,491,403 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $26,297,843 |
Value of interest in pooled separate accounts at end of year | 2021-12-31 | $1,157,895 |
Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $956,168 |
Interest on participant loans | 2021-12-31 | $2,846 |
Interest earned on other investments | 2021-12-31 | $160,121 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $5,536,581 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $5,621,988 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2021-12-31 | $150,876 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $3,917,429 |
Net investment gain/loss from pooled separate accounts | 2021-12-31 | $172,375 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $1,347,570 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $410,052 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | GELMAN ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2021-12-31 | 521392008 |
2020 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2020 401k financial data |
---|
Total income from all sources (including contributions) | 2020-12-31 | $7,322,148 |
Total of all expenses incurred | 2020-12-31 | $1,169,800 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $1,063,069 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $3,010,005 |
Value of total assets at end of year | 2020-12-31 | $32,918,625 |
Value of total assets at beginning of year | 2020-12-31 | $26,766,277 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $106,731 |
Total interest from all sources | 2020-12-31 | $168,922 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $1,031,810 |
Participant contributions at end of year | 2020-12-31 | $42,626 |
Participant contributions at beginning of year | 2020-12-31 | $49,981 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $678,043 |
Other income not declared elsewhere | 2020-12-31 | $178,156 |
Administrative expenses (other) incurred | 2020-12-31 | $106,731 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $6,152,348 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $32,918,625 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $26,766,277 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $26,297,843 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $20,752,597 |
Value of interest in pooled separate accounts at end of year | 2020-12-31 | $956,168 |
Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $959,287 |
Interest on participant loans | 2020-12-31 | $2,760 |
Interest earned on other investments | 2020-12-31 | $166,162 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $5,621,988 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $5,004,412 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $31,665 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $3,973,014 |
Net investment gain/loss from pooled separate accounts | 2020-12-31 | $-7,949 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $1,300,152 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $1,031,404 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | GELMAN ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2020-12-31 | 521392008 |
2019 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2019 401k financial data |
---|
Total income from all sources (including contributions) | 2019-12-31 | $6,082,875 |
Total of all expenses incurred | 2019-12-31 | $673,522 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $669,253 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,072,702 |
Value of total assets at end of year | 2019-12-31 | $26,766,277 |
Value of total assets at beginning of year | 2019-12-31 | $21,356,924 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $4,269 |
Total interest from all sources | 2019-12-31 | $158,818 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $867,628 |
Participant contributions at end of year | 2019-12-31 | $49,981 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $61,552 |
Other income not declared elsewhere | 2019-12-31 | $157,316 |
Administrative expenses (other) incurred | 2019-12-31 | $4,269 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $5,409,353 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $26,766,277 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $21,356,924 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $20,752,597 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $17,051,031 |
Value of interest in pooled separate accounts at end of year | 2019-12-31 | $959,287 |
Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $873,864 |
Interest on participant loans | 2019-12-31 | $143 |
Interest earned on other investments | 2019-12-31 | $158,675 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $5,004,412 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $3,432,029 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $3,644,989 |
Net investment gain/loss from pooled separate accounts | 2019-12-31 | $49,050 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $1,143,522 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $669,253 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | GELMAN ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2019-12-31 | 521392008 |
2018 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2018 401k financial data |
---|
Total income from all sources (including contributions) | 2018-12-31 | $1,201,096 |
Total of all expenses incurred | 2018-12-31 | $153,131 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $153,131 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $2,300,584 |
Value of total assets at end of year | 2018-12-31 | $21,356,924 |
Value of total assets at beginning of year | 2018-12-31 | $20,308,959 |
Total interest from all sources | 2018-12-31 | $17,709 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $862,476 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $313,613 |
Other income not declared elsewhere | 2018-12-31 | $128,555 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $1,047,965 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $21,356,924 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $20,308,959 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $17,051,031 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $16,496,919 |
Value of interest in pooled separate accounts at end of year | 2018-12-31 | $873,864 |
Value of interest in pooled separate accounts at beginning of year | 2018-12-31 | $789,403 |
Interest earned on other investments | 2018-12-31 | $17,709 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2018-12-31 | $3,432,029 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2018-12-31 | $3,022,637 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-1,284,703 |
Net investment gain/loss from pooled separate accounts | 2018-12-31 | $38,951 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $1,124,495 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $153,131 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | GELMAN, ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2018-12-31 | 521392008 |
2017 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2017 401k financial data |
---|
Total income from all sources (including contributions) | 2017-12-31 | $4,495,216 |
Total of all expenses incurred | 2017-12-31 | $194,688 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $194,688 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $1,957,498 |
Value of total assets at end of year | 2017-12-31 | $20,308,959 |
Value of total assets at beginning of year | 2017-12-31 | $16,008,431 |
Total interest from all sources | 2017-12-31 | $13,833 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $714,274 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $244,890 |
Other income not declared elsewhere | 2017-12-31 | $110,914 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $4,300,528 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $20,308,959 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $16,008,431 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $16,496,919 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $12,436,956 |
Value of interest in pooled separate accounts at end of year | 2017-12-31 | $789,403 |
Value of interest in pooled separate accounts at beginning of year | 2017-12-31 | $758,398 |
Interest earned on other investments | 2017-12-31 | $13,833 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2017-12-31 | $3,022,637 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2017-12-31 | $2,813,077 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $2,378,897 |
Net investment gain/loss from pooled separate accounts | 2017-12-31 | $34,074 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $998,334 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $194,688 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | GELMAN, ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2017-12-31 | 521392008 |
2016 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2016 401k financial data |
---|
Total income from all sources (including contributions) | 2016-12-31 | $2,937,371 |
Total of all expenses incurred | 2016-12-31 | $207,134 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $207,134 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $2,015,033 |
Value of total assets at end of year | 2016-12-31 | $16,008,431 |
Value of total assets at beginning of year | 2016-12-31 | $13,278,194 |
Total interest from all sources | 2016-12-31 | $21,380 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Contributions received from participants | 2016-12-31 | $600,418 |
Participant contributions at beginning of year | 2016-12-31 | $21,053 |
Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $608,075 |
Other income not declared elsewhere | 2016-12-31 | $88,702 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $2,730,237 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $16,008,431 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $13,278,194 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $12,436,956 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $9,888,756 |
Value of interest in pooled separate accounts at end of year | 2016-12-31 | $758,398 |
Value of interest in pooled separate accounts at beginning of year | 2016-12-31 | $782,474 |
Interest earned on other investments | 2016-12-31 | $21,380 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2016-12-31 | $2,813,077 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2016-12-31 | $2,556,822 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $774,174 |
Net investment gain/loss from pooled separate accounts | 2016-12-31 | $38,082 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $806,540 |
Employer contributions (assets) at beginning of year | 2016-12-31 | $29,089 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $207,134 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2016-12-31 | No |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
Accountancy firm name | 2016-12-31 | GELMAN, ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2016-12-31 | 521392008 |
2015 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2015 401k financial data |
---|
Total income from all sources (including contributions) | 2015-12-31 | $1,653,242 |
Total of all expenses incurred | 2015-12-31 | $516,142 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $516,142 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $1,572,416 |
Value of total assets at end of year | 2015-12-31 | $13,278,194 |
Value of total assets at beginning of year | 2015-12-31 | $12,141,094 |
Total interest from all sources | 2015-12-31 | $14,938 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
Value of fidelity bond cover | 2015-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Contributions received from participants | 2015-12-31 | $504,515 |
Participant contributions at end of year | 2015-12-31 | $21,053 |
Participant contributions at beginning of year | 2015-12-31 | $19,955 |
Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $353,528 |
Other income not declared elsewhere | 2015-12-31 | $74,013 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $1,137,100 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $13,278,194 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $12,141,094 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $9,888,756 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $8,969,099 |
Value of interest in pooled separate accounts at end of year | 2015-12-31 | $782,474 |
Value of interest in pooled separate accounts at beginning of year | 2015-12-31 | $737,015 |
Interest earned on other investments | 2015-12-31 | $14,938 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2015-12-31 | $2,556,822 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2015-12-31 | $2,390,450 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-67,143 |
Net investment gain/loss from pooled separate accounts | 2015-12-31 | $59,018 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
Contributions received in cash from employer | 2015-12-31 | $714,373 |
Employer contributions (assets) at end of year | 2015-12-31 | $29,089 |
Employer contributions (assets) at beginning of year | 2015-12-31 | $24,575 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $516,142 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2015-12-31 | No |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
Accountancy firm name | 2015-12-31 | GELMAN, ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2015-12-31 | 521392008 |
2014 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2014 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $0 |
Total transfer of assets to this plan | 2014-12-31 | $0 |
Total transfer of assets from this plan | 2014-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $2,387,396 |
Total loss/gain on sale of assets | 2014-12-31 | $0 |
Total of all expenses incurred | 2014-12-31 | $265,195 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $265,195 |
Expenses. Certain deemed distributions of participant loans | 2014-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $1,654,188 |
Value of total assets at end of year | 2014-12-31 | $12,141,094 |
Value of total assets at beginning of year | 2014-12-31 | $10,018,893 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $0 |
Total interest from all sources | 2014-12-31 | $85,199 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $0 |
Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
Value of fidelity bond cover | 2014-12-31 | $50,000 |
If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2014-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Contributions received from participants | 2014-12-31 | $473,004 |
Participant contributions at end of year | 2014-12-31 | $0 |
Participant contributions at beginning of year | 2014-12-31 | $0 |
Participant contributions at end of year | 2014-12-31 | $19,955 |
Participant contributions at beginning of year | 2014-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2014-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2014-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $565,191 |
Other income not declared elsewhere | 2014-12-31 | $0 |
Administrative expenses (other) incurred | 2014-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $2,122,201 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $12,141,094 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $10,018,893 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Investment advisory and management fees | 2014-12-31 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $8,969,099 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $7,293,593 |
Value of interest in pooled separate accounts at end of year | 2014-12-31 | $737,015 |
Value of interest in pooled separate accounts at beginning of year | 2014-12-31 | $608,222 |
Interest on participant loans | 2014-12-31 | $0 |
Interest earned on other investments | 2014-12-31 | $85,199 |
Value of interest in master investment trust accounts at end of year | 2014-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2014-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2014-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $0 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2014-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at end of year | 2014-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2014-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2014-12-31 | $2,390,450 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2014-12-31 | $2,117,078 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2014-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $569,389 |
Net investment gain/loss from pooled separate accounts | 2014-12-31 | $78,620 |
Net investment gain or loss from common/collective trusts | 2014-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
Contributions received in cash from employer | 2014-12-31 | $615,993 |
Employer contributions (assets) at end of year | 2014-12-31 | $24,575 |
Employer contributions (assets) at beginning of year | 2014-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $265,195 |
Contract administrator fees | 2014-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2014-12-31 | No |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
Accountancy firm name | 2014-12-31 | GELMAN, ROSENBERG, AND FREEDMAN |
Accountancy firm EIN | 2014-12-31 | 521392008 |
2013 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2013 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
Total transfer of assets to this plan | 2013-12-31 | $0 |
Total transfer of assets from this plan | 2013-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $697 |
Total income from all sources (including contributions) | 2013-12-31 | $2,445,536 |
Total loss/gain on sale of assets | 2013-12-31 | $0 |
Total of all expenses incurred | 2013-12-31 | $72,153 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $72,153 |
Expenses. Certain deemed distributions of participant loans | 2013-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $1,073,517 |
Value of total assets at end of year | 2013-12-31 | $10,018,893 |
Value of total assets at beginning of year | 2013-12-31 | $7,646,207 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $0 |
Total interest from all sources | 2013-12-31 | $76,701 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $0 |
Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
Value of fidelity bond cover | 2013-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2013-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Contributions received from participants | 2013-12-31 | $417,350 |
Participant contributions at end of year | 2013-12-31 | $0 |
Participant contributions at beginning of year | 2013-12-31 | $0 |
Participant contributions at beginning of year | 2013-12-31 | $0 |
Assets. Other investments not covered elsewhere at end of year | 2013-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2013-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $111,642 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2013-12-31 | $697 |
Other income not declared elsewhere | 2013-12-31 | $0 |
Administrative expenses (other) incurred | 2013-12-31 | $0 |
Total non interest bearing cash at end of year | 2013-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2013-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $2,373,383 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $10,018,893 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $7,645,510 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Investment advisory and management fees | 2013-12-31 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $7,293,593 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $5,135,886 |
Value of interest in pooled separate accounts at end of year | 2013-12-31 | $608,222 |
Value of interest in pooled separate accounts at beginning of year | 2013-12-31 | $548,328 |
Interest on participant loans | 2013-12-31 | $0 |
Interest earned on other investments | 2013-12-31 | $76,701 |
Value of interest in master investment trust accounts at end of year | 2013-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2013-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2013-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at end of year | 2013-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2013-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2013-12-31 | $2,117,078 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2013-12-31 | $1,961,993 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2013-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $1,242,674 |
Net investment gain/loss from pooled separate accounts | 2013-12-31 | $52,644 |
Net investment gain or loss from common/collective trusts | 2013-12-31 | $0 |
Net gain/loss from 103.12 investment entities | 2013-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
Contributions received in cash from employer | 2013-12-31 | $544,525 |
Employer contributions (assets) at beginning of year | 2013-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $72,153 |
Contract administrator fees | 2013-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2013-12-31 | No |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
Accountancy firm name | 2013-12-31 | GELMAN, ROSEBERG & FREEDMAN |
Accountancy firm EIN | 2013-12-31 | 521392008 |
2012 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2012 401k financial data |
---|
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $697 |
Total income from all sources (including contributions) | 2012-12-31 | $1,545,624 |
Total of all expenses incurred | 2012-12-31 | $39,729 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $39,729 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $826,180 |
Value of total assets at end of year | 2012-12-31 | $7,646,207 |
Value of total assets at beginning of year | 2012-12-31 | $6,139,615 |
Total interest from all sources | 2012-12-31 | $66,155 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $0 |
Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
Value of fidelity bond cover | 2012-12-31 | $250,000 |
If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2012-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Contributions received from participants | 2012-12-31 | $345,130 |
Participant contributions at beginning of year | 2012-12-31 | $12,594 |
Income. Received or receivable in cash from other sources (including rollovers) | 2012-12-31 | $6,112 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2012-12-31 | $697 |
Other income not declared elsewhere | 2012-12-31 | $0 |
Total non interest bearing cash at beginning of year | 2012-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $1,505,895 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $7,645,510 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $6,139,615 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $5,135,886 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $4,113,697 |
Value of interest in pooled separate accounts at end of year | 2012-12-31 | $548,328 |
Value of interest in pooled separate accounts at beginning of year | 2012-12-31 | $419,578 |
Interest earned on other investments | 2012-12-31 | $66,155 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2012-12-31 | $1,961,993 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2012-12-31 | $1,577,141 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2012-12-31 | $6,159 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $607,923 |
Net investment gain/loss from pooled separate accounts | 2012-12-31 | $45,366 |
Net gain/loss from 103.12 investment entities | 2012-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
Contributions received in cash from employer | 2012-12-31 | $474,938 |
Employer contributions (assets) at beginning of year | 2012-12-31 | $16,605 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $33,570 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2012-12-31 | No |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Disclaimer |
Accountancy firm name | 2012-12-31 | GELMAN, ROSENBERG & FREEDMAN |
Accountancy firm EIN | 2012-12-31 | 521392008 |
2011 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2011 401k financial data |
---|
Total transfer of assets to this plan | 2011-12-31 | $0 |
Total transfer of assets from this plan | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $817,915 |
Total of all expenses incurred | 2011-12-31 | $155,541 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $155,541 |
Expenses. Certain deemed distributions of participant loans | 2011-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $798,352 |
Value of total assets at end of year | 2011-12-31 | $6,139,615 |
Value of total assets at beginning of year | 2011-12-31 | $5,477,241 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $0 |
Total interest from all sources | 2011-12-31 | $56,528 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $0 |
Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
Value of fidelity bond cover | 2011-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Contributions received from participants | 2011-12-31 | $325,831 |
Participant contributions at end of year | 2011-12-31 | $0 |
Participant contributions at beginning of year | 2011-12-31 | $0 |
Participant contributions at end of year | 2011-12-31 | $12,594 |
Participant contributions at beginning of year | 2011-12-31 | $14,167 |
Assets. Other investments not covered elsewhere at end of year | 2011-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2011-12-31 | $38,962 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2011-12-31 | $0 |
Administrative expenses (other) incurred | 2011-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $662,374 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $6,139,615 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $5,477,241 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Investment advisory and management fees | 2011-12-31 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $4,113,697 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $3,754,416 |
Value of interest in pooled separate accounts at end of year | 2011-12-31 | $419,578 |
Value of interest in pooled separate accounts at beginning of year | 2011-12-31 | $334,382 |
Interest on participant loans | 2011-12-31 | $0 |
Interest earned on other investments | 2011-12-31 | $56,528 |
Value of interest in master investment trust accounts at end of year | 2011-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2011-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2011-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2011-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at end of year | 2011-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2011-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2011-12-31 | $1,577,141 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2011-12-31 | $1,356,972 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2011-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-82,788 |
Net investment gain/loss from pooled separate accounts | 2011-12-31 | $45,823 |
Net investment gain or loss from common/collective trusts | 2011-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
Contributions received in cash from employer | 2011-12-31 | $433,559 |
Employer contributions (assets) at end of year | 2011-12-31 | $16,605 |
Employer contributions (assets) at beginning of year | 2011-12-31 | $17,304 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $155,541 |
Contract administrator fees | 2011-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2011-12-31 | No |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Disclaimer |
Accountancy firm name | 2011-12-31 | GELMAN ROSENBERG AND FREEDMAN CPAS |
Accountancy firm EIN | 2011-12-31 | 521392008 |
2010 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2010 401k financial data |
---|
Total transfer of assets to this plan | 2010-12-31 | $0 |
Total transfer of assets from this plan | 2010-12-31 | $0 |
Total income from all sources (including contributions) | 2010-12-31 | $1,237,272 |
Total of all expenses incurred | 2010-12-31 | $32,058 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $32,058 |
Expenses. Certain deemed distributions of participant loans | 2010-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $726,474 |
Value of total assets at end of year | 2010-12-31 | $5,477,241 |
Value of total assets at beginning of year | 2010-12-31 | $4,272,027 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $0 |
Total interest from all sources | 2010-12-31 | $46,268 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $0 |
Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
Value of fidelity bond cover | 2010-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2010-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
Contributions received from participants | 2010-12-31 | $319,480 |
Participant contributions at end of year | 2010-12-31 | $0 |
Participant contributions at beginning of year | 2010-12-31 | $0 |
Participant contributions at end of year | 2010-12-31 | $14,167 |
Assets. Other investments not covered elsewhere at end of year | 2010-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2010-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $0 |
Other income not declared elsewhere | 2010-12-31 | $0 |
Administrative expenses (other) incurred | 2010-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Income. Non cash contributions | 2010-12-31 | $0 |
Value of net income/loss | 2010-12-31 | $1,205,214 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $5,477,241 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $4,272,027 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Investment advisory and management fees | 2010-12-31 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $3,754,416 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $2,841,537 |
Value of interest in pooled separate accounts at end of year | 2010-12-31 | $334,382 |
Value of interest in pooled separate accounts at beginning of year | 2010-12-31 | $242,699 |
Interest on participant loans | 2010-12-31 | $0 |
Interest earned on other investments | 2010-12-31 | $46,268 |
Value of interest in master investment trust accounts at end of year | 2010-12-31 | $0 |
Value of interest in master investment trust accounts at beginning of year | 2010-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2010-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2010-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at end of year | 2010-12-31 | $0 |
Assets. Value of investments in 103.12 investment entities at beginning of year | 2010-12-31 | $0 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2010-12-31 | $1,356,972 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2010-12-31 | $1,187,791 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2010-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $426,650 |
Net investment gain/loss from pooled separate accounts | 2010-12-31 | $37,880 |
Net investment gain or loss from common/collective trusts | 2010-12-31 | $0 |
Net gain/loss from 103.12 investment entities | 2010-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
Contributions received in cash from employer | 2010-12-31 | $406,994 |
Employer contributions (assets) at end of year | 2010-12-31 | $17,304 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $32,058 |
Contract administrator fees | 2010-12-31 | $0 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2010-12-31 | No |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Disclaimer |
Accountancy firm name | 2010-12-31 | GELMAN ROSENBERG AND FREEDMAN CPAS |
Accountancy firm EIN | 2010-12-31 | 521392008 |
2009 : AMERICAN SOCIETY OF HEMATOLOGY 403(B) PLAN 2009 401k financial data |
---|
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |